Basingstoke & North Hampshire Hospital is seeking funding for the Nox T3s Diagnostic Sleep Study Device, poised to revolutionise sleep disorder diagnosis and treatment. This state of the art wearable technology offers unparalleled diagnostic capability, filling critical gaps left by current equipment, enabling the identification of conditions like periodic limb movement disorder (PLMD), which is notoriously challenging to diagnose. 

By funding the acquisition of the Nox T3s, donors will directly impact over 100 patients annually in Hampshire, facilitating swifter and more accurate diagnoses and significantly advancing sleep disorder management and patient care.